S&P 500   4,307.42 (-0.44%)
DOW   33,890.23 (-0.79%)
QQQ   340.16 (-0.28%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,307.42 (-0.44%)
DOW   33,890.23 (-0.79%)
QQQ   340.16 (-0.28%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,307.42 (-0.44%)
DOW   33,890.23 (-0.79%)
QQQ   340.16 (-0.28%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
S&P 500   4,307.42 (-0.44%)
DOW   33,890.23 (-0.79%)
QQQ   340.16 (-0.28%)
AAPL   164.97 (+3.61%)
MSFT   297.93 (-0.64%)
FB   293.48 (-0.39%)
GOOGL   2,576.43 (-0.14%)
AMZN   2,764.11 (-1.03%)
TSLA   826.54 (-0.31%)
NVDA   215.65 (-1.73%)
BABA   110.42 (-1.23%)
NIO   19.91 (-5.68%)
AMD   101.29 (-1.28%)
CGC   6.83 (-0.29%)
MU   76.32 (-3.05%)
GE   89.26 (-0.71%)
T   24.37 (+1.04%)
F   19.09 (-2.35%)
DIS   134.67 (-0.55%)
AMC   13.73 (-5.44%)
PFE   53.81 (+0.82%)
ACB   3.74 (-1.32%)
BA   184.69 (-2.67%)
NASDAQ:SURG

SurgePays Stock Forecast, Price & News

$2.85
-0.13 (-4.36%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.84
$3.01
50-Day Range
$1.88
$3.29
52-Week Range
$1.76
$4.24
Volume
70,921 shs
Average Volume
295,642 shs
Market Capitalization
$34.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SURG News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.


SurgePays logo

About SurgePays

SurgePays, Inc. operates as a technology-driven company, which focuses on building a supply chain software platform as an alternative to traditional wholesale supply chain distribution models. It offers goods and services direct to convenience stores, bodegas, minimarts, tiendas and other corner stores, providing goods and services primarily to the underbanked community. The company was founded on August 18, 2006 and is headquartered in Bartlett, TN.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Advertising
Sub-Industry
N/A
Current Symbol
NASDAQ:SURG
Fax
N/A
Employees
31
Year Founded
N/A

Sales & Book Value

Annual Sales
$54.41 million

Profitability

Net Income
$-10.72 million
Pretax Margin
-19.55%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$34.33 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/16/2021
Today
1/28/2022
Next Earnings (Estimated)
4/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.97 out of 5 stars

Computer And Technology Sector

493rd out of 897 stocks

Advertising Industry

6th out of 13 stocks

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












SurgePays (NASDAQ:SURG) Frequently Asked Questions

Is SurgePays a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SurgePays in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SurgePays stock.
View analyst ratings for SurgePays
or view top-rated stocks.

How has SurgePays' stock been impacted by Coronavirus (COVID-19)?

SurgePays' stock was trading at $0.2965 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SURG stock has increased by 861.2% and is now trading at $2.85.
View which stocks have been most impacted by COVID-19
.

Are investors shorting SurgePays?

SurgePays saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 352,600 shares, an increase of 67.9% from the December 31st total of 210,000 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is currently 0.3 days. Currently, 3.2% of the company's shares are sold short.
View SurgePays' Short Interest
.

When is SurgePays' next earnings date?

SurgePays is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for SurgePays
.

How were SurgePays' earnings last quarter?

SurgePays, Inc. (NASDAQ:SURG) announced its earnings results on Tuesday, November, 16th. The medical equipment provider reported ($0.51) earnings per share for the quarter. The medical equipment provider earned $14.54 million during the quarter.
View SurgePays' earnings history
.

What price target have analysts set for SURG?

1 brokerages have issued 1 year target prices for SurgePays' stock. Their forecasts range from $7.00 to $7.00. On average, they expect SurgePays' stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 145.6% from the stock's current price.
View analysts' price targets for SurgePays
or view top-rated stocks among Wall Street analysts.

Who are SurgePays' key executives?

SurgePays' management team includes the following people:
  • Kevin Brian Cox, Chairman & Chief Executive Officer
  • Anthony P. Nuzzo, President, Chief Operating Officer & Director
  • Anthony G. Evers, Chief Financial Officer
  • John Mott, Chief Technology Officer (LinkedIn Profile)
  • David C. Ansani, Secretary, CAO & Chief Legal Counsel

What other stocks do shareholders of SurgePays own?

What is SurgePays' stock symbol?

SurgePays trades on the NASDAQ under the ticker symbol "SURG."

Who are SurgePays' major shareholders?

SurgePays' stock is owned by a variety of retail and institutional investors. Top institutional investors include Kestra Advisory Services LLC (0.41%). Company insiders that own SurgePays stock include David Allen May, John Mott and Kevin Brian Cox.
View institutional ownership trends for SurgePays
.

Which major investors are buying SurgePays stock?

SURG stock was bought by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC. Company insiders that have bought SurgePays stock in the last two years include David Allen May, John Mott, and Kevin Brian Cox.
View insider buying and selling activity for SurgePays
or or view top insider-buying stocks.

How do I buy shares of SurgePays?

Shares of SURG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SurgePays' stock price today?

One share of SURG stock can currently be purchased for approximately $2.85.

How much money does SurgePays make?

SurgePays has a market capitalization of $34.33 million and generates $54.41 million in revenue each year.

How many employees does SurgePays have?

SurgePays employs 31 workers across the globe.

What is SurgePays' official website?

The official website for SurgePays is www.surgeholdings.com.

Where are SurgePays' headquarters?

How can I contact SurgePays?

SurgePays' mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The medical equipment provider can be reached via phone at (901) 302-9587 or via email at [email protected].


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.